Stimulants affect the mind, brain, and body in several ways, many of which can be very positive, even in the long run. Find ...
Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...
Progressive and incurable, Alzheimer’s disease affects an estimated 6.7 million U.S. adults at least 65 years old, according ...
Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...
Reduced baroreflex sensitivity is tied to an increased risk for dementia in older adults who do not take antihypertensive medications.
A Georgia community is in mourning following the unexpected death of a veteran police officer. According to the Duluth Police ...
Metformin, a widely used medication for type 2 diabetes, may also help slow cognitive decline and reduce the risk of dementia, according to a study from UNSW Sydney. The research suggests that ...
There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...
This led them to the conclusion that antibiotics, antivirals and anti-inflammatory drugs were all associated with reduced ...
New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...
CNN’s 5 Things newsletter is your one-stop shop for the latest headlines and fascinating stories to start and end your ...
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results